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Abstract 
Purpose: This study was aimed to evaluate the antioxidant activity of the methanol extract of Euphorbia 
spinidens Bornm (Euphorbiaceae) and its effect on Herpes simplex virus type-1 (HSV-1) replication.  
Methods: The methanol extract of aerial parts of E. spinidens collected from Khorasan State in North-
Eastern part of Iran was used in this study. Total phenolic, flavonoid contents and the antioxidant 
activity were evaluated using Folin-Ciocalteu method, aluminum chloride colorimetric method and β-
carotene-linoleate model system, respectively. Both the cytotoxic and antiviral effects of  the crude 
extract on Vero cell line were determined by quantifying the viability of Vero cells using 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)2H-tetrazolium (MTS) assay.  
Results: Total phenolic and flavonoid contents of E.spinidens were 70 ± 1 mg of  gallic acid  
equivalent/g  of dry extract (mg GAE/g extract) and 49.66 ± 1.00 mg rutin equivalent/g of dry extract (mg 
RTN/g extract), respectively. Antioxidant activity was 44 ± 1 % compared with the standard, buthylated 
hydroxytuloene (BHT). The 50 % cytotoxic concentration (CC50) of the extract on Vero cells was 5.072 ± 
0.063 mg/ml and its antiviral concentration of 50 % effectiveness (EC50) value was 0.34 ± 0.003 mg/ml.  
Conclusion: The findings of this study show that the methanol extract of E. spinidens has high content 
of phenolic and flavonoid compounds with good antioxidant activity. Furthermore, this extract has 
significant antiviral effect on HSV-1 probably due to the inhibition of viral replication.   
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INTRODUCTION 
 
Herpes simplex viruses (HSV) are endemic in 
through human populations and pathogenic to 
human. Nucleoside derivative drugs such as 
acyclovir (AVC), gancyclovir (GCV) and 
pencyclovir (PCV) have been widely authorized 
drugs for the treatment of HSV infections [1]. 
However, the increased and protracted use of 
these compounds in clinical setting, especially for 
the therapy of immunocompromised patients, 
has led to the emergence of viral resistance 
against most of these drugs [2]. In order to tackle 
the problem of viral resistance, development of 
new antiviral products with various mechanisms 
of action are very much required. 
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Medicinal plants have been used for many years 
for the treatment of human diseases [3] and a 
number of herbal medicines have been 
developed into therapeutic agents or have had 
promising results [4-7]. Plants have the ability to 
synthesize a wide array of compounds and have 
long been used as remedies, and many are now 
being collected and examined in an attempt to 
identify possible sources of drugs [8-10]. The 
compounds with natural origin, especially herbal 
medicines, have been shown to be reliable 
source of new drugs [11-13].  
 
The Euphorbia is the largest genus in the plant 
family Euphorbiaceae, containing about 2,000 
known species [14]. The plants synthesize large 
number of diverse secondary metabolites such 
as terpenoids [15], polyphenols, flavonoids and 
tannins [16]. Some species of the genus 
Euphorbia have been exploited as medicinal 
plants for the treatment of skin diseases, 
migraine, gonorrhea and intestinal parasites and 
as wart cures [17]. Researchers have shown that 
Euphorbia species have antiproliferative activity, 
cytotoxicity, antipyretic-analgesic activity and 
also inhibitory activity on the HIV-1 infection [18]. 
Therefore, this study was aimed to evaluate both 
antioxidant and anti-HSV-1 activities of the 
methanol extract of aerial parts of E. spinidens, 
grown in Iran.  
 
EXPERIMENTAL  
 
Plant material 
 
Aerial parts of E. spinidens were collected in 
June 2011 from the wild populations growing in 
Northern Khorasan Province of Iran. The plant 
material was authenticated by Dr Ghorayshol 
Hosseini of Herbaceous Science Research 
Center at Ferdowsi University, Mashhad, Iran 
and a voucher specimen (no. 43033) was 
deposited at the center’s herbarium. 
 
Preparation of plant extract 
 
Air-dried plant material (3 kg) was macerated 
with 15 L methanol (96 %) at room temperature 
(RT) for 5 days. The extract was filtered and 
concentrated under reduced pressure to yield 
134 g crude extract. 
 
Determination of total phenolic, flavonoid 
contents and antioxidant activity of the 
extract 
 
The total phenolic content of the extract was 
estimated by Folin Ciocalteu method [19], with 
some modifications. Briefly, 0.01 g of dried 
extracts was dissolved in 10 mL of 60 % 
methanol. Thereafter, 0.1 ml of extract solution 
was added followed by 0.5 ml of 10% Folin 
Ciocalteu reagent and after 4 to 8 min were 
mixed with 0.4 ml of 7.5 % aqueous sodium 
bicarbonate. The mixture was kept for 30 min at 
RT and then the total phenols were determined 
by spectrophotometrically at 765 nm (Unico UV-
2100, USA). The results are expressed as mg of 
gallic acid equivalents/g of extract (GAEs). 
 
Aluminum chloride colorimetric method was used 
for flavonoids determination with some 
modifications [4]. Briefly, 0.01 g of dried extracts 
was dissolved in 10 mL of 60 % methanol. 1 ml 
of extract solution was mixed with 1 mL of 2 % 
aluminum chloride and 6 mL of 5 % potassium 
acetate. Following incubation for 40 min. at RT, 
the absorbance of the reaction mixture was 
measured at 415 nm spectrophotometrically. The 
amount of 2 % aluminum chloride was 
substituted by the same amount of distilled water 
in the blank. Total flavonoids were expressed in 
terms of rutin equivalent (RE) (mg/g).   
 
Total antioxidant capacity of E. spinidens 
extracts was assayed using the β-carotene and 
linoleic acid [20]. A stock solution of β-carotene 
(0.5 mg) in 1 mL of chloroform, linoleic acid (25 
µl), and Tween-40 (200 mg) was prepared and 
chloroform completely evaporated using a 
vacuum evaporator at 50 ºC. Thereafter, 100 mL 
of oxygenated water (30 min 100 ml/min) were 
added under vigorous shaking. 2500 µl aliquots 
of this emulsion were added to test tubes and 
350 µl of the extracts prepared at 2g/l 
concentrations were added and incubated for 48 
h at room temperature. The same procedure was 
repeated with BHT (as positive control) and a 
blank. The absorbance of the solutions was 
measured at 490 nm. Antioxidant capacities of 
the extracts were compared with those of BHT 
and blank. 
 
Cell culture and virus  
 
African green monkey kidney cell line (Vero cell 
line, ATCC C102) was kindly provided by 
Pasteure Institute of Iran. The cells were grown 
in Dulbecco's Modified Eagle's Medium (DMEM; 
Sigma, USA) supplemented with 10 % of fetal 
bovine serum (FBS; Gibco,  Germany), 100 
µg/mL of streptomycin, 100 UI/ml of penicillin 
and 0.25 µg/mL amphotericin B (Gibco,  
Germany),  at 37 °C and 5 % CO2. The same 
medium containing 2 % PBS was used for 
cytotoxicity and antiviral assays. HSV-1 (HSV-1, 
KOS strain) was kindly provided by Department 
of virology, University of Tarbiat Modares, 
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Tehran, Iran. Virus stock was prepared by 
infection of confluent monolayer Vero cells in 75 
cm2 culture flasks using DMEM medium with 2 % 
FBS, at 37 °C in 5 % CO2. Virus titer was 
determined by cytopathic effect (CPE) of HSV-1 
in Vero cells and was expressed as the 50 % 
Tissue Culture Infective Dose (TCID50) per ml 
using the formula of Spearman–Karber [21]. 
 
Cytotoxicity assay 
 
Prior to the investigation of anti-HSV-1 activity, 
the cytotoxic effect of the extract was 
determined. Briefly, Vero cells were seeded onto 
96-well plates with a concentration of 3.5 × 105  
cells/well with final volume of 100 µl per well. 
After incubation at 37 °C with 5 % CO2 for 24 h, 
when the cell monolayer was confluent, the cell 
culture medium of cells aspirated and washed 
with PBS. Extracts were serially diluted with the 
culture medium supplemented with 2 % serum to 
reach the various concentrations. Negative 
control dilution of dimethyl sulphoxide (DMSO) at 
0.1 % was also included.  
 
Cells were incubated with 100 µL/well of various 
concentrations of the extract or DMSO (in 
triplicates). After incubation at 37 °C with 5 % 
CO2 for 3 days, MTS [3(4,5 
dimethylthiazol2yl)5(3carboxymethoxyphenyl)-2-
(4-sulfophenyl)2H-tetrazolium] (Cell Titer 96; 
Promega, USA) was added to each well with a 
volume of 20 µL. The trays were further 
incubated for 2 h to allow MTS production. The 
absorbances were determined with an ELISA 
reader (StataFax 2100, USA) at a test 
wavelength of 490 nm. Data were calculated as 
the percentage of toxicity using Eq 1. 
 
Toxicity (%) = {100 – (At/As)100} …………. (1) 
 
where At and As refer to the absorbance of the 
test and control, respectively [21]. The 50 % 
cytotoxic concentration (CC50) was defined as 
the cytotoxic concentration of the crude extract 
by regression analysis. 
 
Antiviral assay 
 
The virus induced cytopathic effect (CPE) was 
defined by MTS method. Approximately, 5 × 105 
Vero cells/well were seeded onto 96-well plates 
with final volume of 100 µL per well and cultured 
for 24 h at 37 °C. When the cell monolayers were 
confluent, the medium was removed from the 
wells and 100 µL of test virus (100TCID50) was 
added and incubated for another 2 h. Various 
non-cytotoxic concentrations (≤ CC50 values) of 
the crude extract were then added to culture 
wells in triplicate test. The maximum 
concentration of DMSO (0.1 %) was used as a 
negative control. Aciclovir (9-(2-
hydroxyethoxymethyl; Sigma, USA) was used as 
a positive control for HSV-1. After incubation at 
37 °C with 5 % CO2 for 72 h, MTS was added to 
each well with a volume of 20 µL. The trays were 
renewed incubated for 2 h to allow MTS 
production. The absorbances were determined 
with an enzyme-linked immunosorbent assay 
(ELISA) reader (Stata  Fax  2100, USA) at a test 
wavelength of 490 nm. Viral inhibition rate (V) 
was estimated as in Eq 2 [13]. 
 
V = (Atv – Acv)/(Acd – Acv)100 …………….(2)  
 
where Atv is the absorbance of the test 
compounds with virus infected cells.  Acv and 
Acd are the absorbance of virus control and of 
cell control, respectively. The procedure was 
carried out three times. The 50 % effectiveness 
concentration (EC50) was determined from a 
curve relating inhibition to the concentration of 
the extract by regression analysis. Selectivity 
index (SI), as a marker of antiviral activity, was 
determined as the ratio of CC50 to EC50. 
 
To analyze the dose-dependent effect of the test 
drugs on infected Vero cells, different 
concentrations of the extract was added to HSV-
1 infected Vero cell culture in triplicate. After 2–
3 days MTT assay was carried out to determine 
the inhibition of infection caused by the HSV, as 
described previously [22]. 
 
Time-course anti-virus analysis  
 
Time-course analysis was carried out to 
investigate the period of time (stage) during 
which, the extract inhibits HSV-1 replication. This 
experiment, in which HSV-1 infected cells were 
treated with different doses of the extract at 1 h 
before and 24 h after the infection, was carried 
out according to previously described procedures 
with minor modifications [21]. In brief, 
approximately, 5 × 105 Vero cells/well were 
seeded onto 96-well plates with final volume of 
100 µL per well and cultured for 24 h at 37 °C. 
When the cell monolayer's were confluent, the 
medium was removed from the wells and 100 µL 
of virus (100 TCID50 per well) was added and 
incubated for another 2 h. Various non-cytotoxic 
concentrations (≤ CC50 values) of crude extract 
were added to culture cells in triplicate at various 
times pre-infection (−1 h), co-infection (0 h) or 
post-infection (2, 4, 8 and 24 h). HSV-1(100 
TCID50 per well) was inoculated onto confluent 
monolayers of Vero cells for 2 h. After 72 h, MTS 
test and antiviral activity were carried out as 
previously explained. 
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Statistical analysis 
 
All experiments were carried out in triplicate. 
EC50 and CC50 values were calculated using 
dose-response analyses and related models with 
linear regression. 
 
RESULTS 
 
Total phenolic and total flavonoid contents of 
crude methanolic extract of E. spinidens were 70 
± 1 mg GAE/g extract and 49.66 ± 0.996 mg 
RTN/g extract respectively. Also, the crude 
methanolic extract of E. spinidens had lower 
antioxidant activity than BHT as reference 
antioxidant (Table 1). 
 
MTS assay was used to determine both 
cytoxicity and antiviral activity of the tested 
agents. The results demonstrated that the CC50 
and EC50 of crude methanolic extract of E. 
spinidens were 5.072 ± 0.063 and 0.34 ± 0.003 
mg/ml respectively. Moreover, the obtained 
results based on EC50 value and selectivity index 
(SI) revealed that the crude methanolic extract 
inhibited HSV-1 (Table 2). 
 
Time course analysis was carried out with crude 
methanolic extract to investigate the mechanism 
of antiviral activity. Inhibition was evaluated by 
MTS assay at 1 h before to 24 h after virus 
infection and of treatment with different doses of 
crude extract and represented as percentage 
inhibition. The results revealed that crude 
methanolic extract of E. spinidens at 5 mg/ml 
concentration exhibited the highest inhibition 
against HSV-1 infection within 2 h post-infection, 
which was during the early period of virus 
replication (Figure 1). 
 
Table 1: Antioxidant activity and total phenolic and flavonoid contents of E.spinidens methanolic extract. 
 
Sample Total phenolicsa 
(mg GAE/g) 
total flavonoidsa 
(mg RTN/g) 
Antioxidant activityab  
(%) 
Extract 70.03 ± 1.12 49.66 ± 0.996 44.04 ± 1.02 
BHT - - 90.06 ± 0.01 
mg GAE/g: mg of  gallic acid  equivalent/g  of dry extract, mg RTN/g: mg rutin equivalent/g of dry extract, BHT: 
Buthylated Hydroxytuloene; aValues are given as mean ± SD (n=3); bβ-carotene-linoleate model 
 
Table 2: Assessment of anti-HSV-1 activity of E.spinidens methanolic extract by MTS assay 
 
Test drug CC50
a 
(mg/ml) 
EC50 a 
(mg/ml) 
Selectivity  index 
(SI) ab 
Extract 5.072 ± 0.063 0.34 ± 0.003 14.917 
Acyclovir >5 0.028 ± 0.001 >178.571 
aValues are given as mean ± S.D (n=3); bSelectivity index (SI) =  CC50/EC50. CC50:50% cytotoxic concentration on 
Vero cells; EC50: 50% effectiveness concentration 
 
 
Figure 1: Inhibitory effect of adding methanol extract of E. spinidens at various times of herpes virus (HSV-1) to 
Vero cells. Various concentrations of E. spinidens methanolic extract were added with the HSV-1 infected Vero 
cells at various times period like pre-infection (-1 h), co-infection (0 h) or post-infection ( 2-24 h). After 3 days of 
incubation at 37°C, inhibition was evaluated by MTS assay and expressed as the inhibition percentage. Each bar 
represents the Mean ± SE of three independent experiments 
 
Karimi et al 
Trop J Pharm Res, April 2016; 15(4): 763  
 
 
Figure 2: Dose-dependent effect of antiviral activity induced by E. spinidens extract. Various concentrations of E. 
spinidens methanolic extract (black bars) or acyclovir (gray bars) were added to HSV-1 infected Vero cells after 1 
h of infection. Inhibition percentage was evaluated by MTS assay after 3 days of incubation at 37°C. Each bar 
represents the Mean ± SE of three independent experiments 
 
To analyze the dose-dependent antiviral activity, 
HSV-1 infected Vero cells were treated with 
various concentrations of the crude methanolic 
extract of E. spinidens in DMSO. Acyclovir and 
DMSO (0.1 %) were used as positive and 
negative control, respectively. The results 
revealed that the crude methanolic extract, at 5 
mg/mL concentration, exhibited about 55 % 
inhibition against HSV-1 replication (Figure 2). 
Also, it was shown that at concentrations 
between 0.07 to 5 mg/mL, there was a good 
correlation between the crude extract 
concentration and HSV-1 inhibition rate. 
 
DISCUSSION 
 
The results of this study showed that the crude 
methanolic extract of E. spinidens possess in 
vitro anti-HSV-1 activity with SI value of 14.917. 
Our findings of time course analysis experiments 
also revealed that the extract exhibited the 
highest inhibition against HSV-1 infection within 
2.0 h post-infection. This may indicate that the 
extract probably interferes with post-absorption 
and early stages of HSV-1 replication.  Similarly, 
it has been reported that the crude methanol 
extract of Mallotus peltatus leaves and Cuminum 
cyminum L seeds inhibited HSV-1 replication in 
the early stage and adsorption, respectively 
[21,22]. These results, together, might indicate 
that some herbal extracts are able to interact with 
this virus in the intracellular stages of replication. 
The results of dose-dependent experiments, 
carried out in this study, in consistent with the 
results of some other reports [23,24] may 
indicate that anti-HSV-1 activity of the crude 
methanolic extract of E. spinidens is dose 
dependent. It has been reported that flavonoids, 
terpenoid, and saponins are the main active 
components of Euphorbia genus which are highly 
extracted by methanol and that the antiviral effect 
of this genus is due to these secondary 
metabolites [14,25-27]. Thus, inhibition of HSV-1 
replication seen in the present study may 
probably be due to the action of these secondary 
metabolites of E. spinidens. 
 
CONCLUSION 
 
Based on our results, crude methanol extract of 
E. spinidens exhibits anti HSV-1 activity. This is 
probably due to the inhibition of early viral 
replication and may be dose-dependent. 
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